Literature DB >> 8103865

Interleukin 10 and immune restoration in common variable immunodeficiency.

S Zielen, P Bauscher, D Hofmann, S C Meuer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8103865

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

Review 1.  Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID).

Authors:  L Hammarström; I Vorechovsky; D Webster
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

2.  Clinical, hematologic, and immunologic effects of interleukin-10 in humans.

Authors:  A C Fuchs; E V Granowitz; L Shapiro; E Vannier; G Lonnemann; J B Angel; J S Kennedy; A R Rabson; E Radwanski; M B Affrime; D L Cutler; P C Grint; C A Dinarello
Journal:  J Clin Immunol       Date:  1996-09       Impact factor: 8.317

3.  Alterations in interleukin secretion (IL-2 and IL-4) by CD4 and CD4 CD45RO cells from common variable immunodeficiency (CVI) patients.

Authors:  J M Ferrer; J Iglesias; M Hernández; N Matamoros
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

4.  Gene expression analysis of peripheral T cells in a subgroup of common variable immunodeficiency shows predominance of CCR7(-) effector-memory T cells.

Authors:  A M Holm; E A Sivertsen; S H Tunheim; T Haug; V Bjerkeli; A Yndestad; P Aukrust; S S Frøland
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

5.  HCV infection in patients with primary defects of immunoglobulin production.

Authors:  I Quinti; F Pandolfi; R Paganelli; D el Salman; A Giovannetti; R Rosso; A Oliva; L Rainaldi; F Aiuti
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

6.  A double-blind, placebo-controlled, crossover therapy study with natural human IL-2 (nhuIL-2) in combination with regular intravenous gammaglobulin (IVIG) infusions in 10 patients with common variable immunodeficiency (CVID).

Authors:  J A Rump; A Jahreis; M Schlesier; S Stecher; H H Peter
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

7.  Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA.

Authors:  F Brière; J M Bridon; D Chevet; G Souillet; F Bienvenu; C Guret; H Martinez-Valdez; J Banchereau
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

Review 8.  Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge.

Authors:  Farnaz Najmi Varzaneh; Bärbel Keller; Susanne Unger; Asghar Aghamohammadi; Klaus Warnatz; Nima Rezaei
Journal:  J Clin Immunol       Date:  2014-05-15       Impact factor: 8.317

9.  Assessment of thymic output in common variable immunodeficiency patients by evaluation of T cell receptor excision circles.

Authors:  V Guazzi; F Aiuti; I Mezzaroma; F Mazzetta; G Andolfi; A Mortellaro; M Pierdominici; R Fantini; M Marziali; A Aiuti
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

10.  Mapping of Signaling Pathways Linked to sIgAD Reveals Impaired IL-21 Driven STAT3 B-Cell Activation.

Authors:  Andri L Lemarquis; Fannar Theodors; Helga K Einarsdottir; Bjorn R Ludviksson
Journal:  Front Immunol       Date:  2019-03-18       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.